The anti-αVβ3 integrin antibody specifically target β3 cysteine loop for which do endothelial and smooth muscle cells utilize to communicate to the cell nucleus that they are adhere adequately to extracellular matrix in order to divide. By blockingαVβ3 ligand occupancy and thereby blocking both SHP-2 and She transfer thus inhibiting IGF-1 stimulated cell growth, the specific antibody can be used to treat kidney disease, nephropathy and inflammatory bowel disease.
Figure 1 Human Anti-αVβ3 Antibody (TAB-0358CL) in SDS-PAGE
SDS-PAGE analysis of TAB-0358CL in non-reduced (Lane 1, 1.5 ug) and β-mercaptoethanol-reduced (Lane 2, 1.5 ug) conditions.
Figure 2 Human Anti-αVβ3 Antibody (TAB-0358CL) in HPLC
The purity of TAB-0358CL was greater than 95% as determined by SEC-HPLC.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for TAB-0358CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.